By clicking the "Unsubscribe" button below, you indicate that you do not wish to receive further e-mails about REXULTI® (brexpiprazole) from Otsuka America Pharmaceutical, Inc. (OAPI) at the following e-mail address:
Please enter a valid e-mail address
Please allow up to 10 business days for your request to go into effect. For more information on OAPI's Privacy Policy, click here.